Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Chamberlain

Showing results (161-170 of 396) with videos related to

Pageof 40
Sort By:
Nature Clinical Practice. Oncology|June 11, 2008
Mechanisms of disease: temozolomide and glioblastoma--look to the futureMaciej M Mrugala, Marc C Chamberlain
The Journal of Comparative Neurology|July 1, 1982
Neuropeptide immunoreactivity in Limulus. I. Substance P-like immunoreactivity in the lateral eye and photocerebrumS C Chamberlain, G A Engbretson
British Medical Bulletin|October 1, 1990
Genetic susceptibility to atherosclerosisJ C Chamberlain, D J Galton
Cancer|July 2, 2009
Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymomaMarc C Chamberlain, Sandra K Johnston
Journal of Neuro-Oncology|August 1, 1990
Temporal lobe ganglioglioma in refractory epilepsy: CT and MR in three casesM C Chamberlain, G A Press
Current Neurology and Neuroscience Reports|February 18, 2011
Adult primary intradural spinal cord tumors: a reviewMarc C Chamberlain, Trent L Tredway
The Journal of Supportive Oncology|October 19, 2011
Neoplastic meningitisAlixis Van Horn, Marc C Chamberlain
Oncology Nursing Forum|October 10, 1998
Leptomeningeal metastasis: pathophysiology, treatment, and nursing managementP A Kormanik, M C Chamberlain
Health Physics|April 1, 1997
A computerized implementation of a non-linear equation to predict barrier shielding requirementsA C Chamberlain, W J Strydom
CNS Oncology|October 29, 2015
Bevacizumab and other novel therapies for recurrent oligodendroglial tumorsSean A Grimm, Marc C Chamberlain
Pageof 40

Showing results (161-170 of 396) with videos related to

Sort By:
Pageof 40
Nature Clinical Practice. Oncology|June 11, 2008
Mechanisms of disease: temozolomide and glioblastoma--look to the futureMaciej M Mrugala, Marc C Chamberlain
The Journal of Comparative Neurology|July 1, 1982
Neuropeptide immunoreactivity in Limulus. I. Substance P-like immunoreactivity in the lateral eye and photocerebrumS C Chamberlain, G A Engbretson
British Medical Bulletin|October 1, 1990
Genetic susceptibility to atherosclerosisJ C Chamberlain, D J Galton
Cancer|July 2, 2009
Temozolomide for recurrent intracranial supratentorial platinum-refractory ependymomaMarc C Chamberlain, Sandra K Johnston
Journal of Neuro-Oncology|August 1, 1990
Temporal lobe ganglioglioma in refractory epilepsy: CT and MR in three casesM C Chamberlain, G A Press
Current Neurology and Neuroscience Reports|February 18, 2011
Adult primary intradural spinal cord tumors: a reviewMarc C Chamberlain, Trent L Tredway
The Journal of Supportive Oncology|October 19, 2011
Neoplastic meningitisAlixis Van Horn, Marc C Chamberlain
Oncology Nursing Forum|October 10, 1998
Leptomeningeal metastasis: pathophysiology, treatment, and nursing managementP A Kormanik, M C Chamberlain
Health Physics|April 1, 1997
A computerized implementation of a non-linear equation to predict barrier shielding requirementsA C Chamberlain, W J Strydom
CNS Oncology|October 29, 2015
Bevacizumab and other novel therapies for recurrent oligodendroglial tumorsSean A Grimm, Marc C Chamberlain
Pageof 40